1. Home
  2. EYE vs SRPT Comparison

EYE vs SRPT Comparison

Compare EYE & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National Vision Holdings Inc.

EYE

National Vision Holdings Inc.

HOLD

Current Price

$28.96

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$16.11

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EYE
SRPT
Founded
1990
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Ophthalmic Goods
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.4B
IPO Year
2017
2000

Fundamental Metrics

Financial Performance
Metric
EYE
SRPT
Price
$28.96
$16.11
Analyst Decision
Strong Buy
Hold
Analyst Count
9
28
Target Price
$29.22
$25.48
AVG Volume (30 Days)
1.0M
2.1M
Earning Date
06-01-2026
06-01-2026
Dividend Yield
N/A
N/A
EPS Growth
202.78
N/A
EPS
0.37
N/A
Revenue
$1,987,488,000.00
$2,198,237,000.00
Revenue This Year
$9.58
N/A
Revenue Next Year
$4.90
N/A
P/E Ratio
$80.76
N/A
Revenue Growth
9.00
15.58
52 Week Low
$10.45
$10.42
52 Week High
$30.02
$107.23

Technical Indicators

Market Signals
Indicator
EYE
SRPT
Relative Strength Index (RSI) 60.93 34.08
Support Level $25.33 $15.51
Resistance Level $29.33 $19.55
Average True Range (ATR) 1.61 0.78
MACD 0.08 -0.16
Stochastic Oscillator 79.49 11.69

Price Performance

Historical Comparison
EYE
SRPT

About EYE National Vision Holdings Inc.

National Vision Holdings Inc is an optical retailer in the U.S. Its product portfolio includes eyeglasses and sunglasses, contact lenses, accessories, and other products. The company has two operating segments; Owned and Host segment includes company-owned brands America's Best and Eyeglass World, In America's Best stores, vision care services are provided by optometrists or by independent professional corporations and Host operating consist of Military and Fred Meyer which provide eye exams by independent optometrists, and the Legacy segment manages the operations of, and supplies inventory and lab processing services to Legacy retail Vision Centers. It earns a majority of its revenue from the Owned and Host segment.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

Share on Social Networks: